<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33982">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02664207</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-15-0795</org_study_id>
    <nct_id>NCT02664207</nct_id>
  </id_info>
  <brief_title>Extended Criteria For Fetal Myelomeningocele Repair</brief_title>
  <official_title>Extended Criteria For Fetal Myelomeningocele Repair: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to offer pre-natal Myelomeningocele (MMC) repair surgery to
      mothers with a BMI of 35-40 kg/m2 (extending the Management of Myelomeningocele Study (MOMs)
      criteria for BMI) and to evaluate the efficacy and safety of this extension, by capturing
      clinical and outcome information.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2015</start_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complications associated with Obesity in Pregnancy and Surgery</measure>
    <time_frame>At the time of fetal repair surgery to 40 weeks gestation</time_frame>
    <description>Determine if there is an increased risk in mothers with a BMI of 35-40 who've undergone open fetal repair for myelomeningocele.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Obesity</condition>
  <condition>Myelomeningocele</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Fetal Surgery:BMI 35-40</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will undergo open fetal repair surgery for myelomeningocele. Our group will meet all criteria previously set by the MOMs trial with the exception of body mass index (BMI). BMI will be extended to 35-40 kg/m2 in this trial.
Intervention: Open Fetal Repair of Myelomeningocele</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open Fetal Repair of Myelomeningocele</intervention_name>
    <description>Maternal Fetal Surgery for Open Neural Tube Defect in women with a BMI of 35 to 40kg/m2</description>
    <arm_group_label>Fetal Surgery:BMI 35-40</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any woman with a prenatal diagnoses of myelomeningocele.

          -  Pre-pregnancy BMI of 35-40 kg/m2.

          -  same MOMs Trial inclusion criteria (with the exception of BMI)

        Exclusion Criteria:

          -  poor glycemic control (i.e., HbA1c â‰¥ 8%) in spite a medical antidiabetic therapy in
             accordance with good clinical practice (GCP)

          -  presence of significant co-morbidities or complications (such as dyslipidemia,
             uncontrolled arterial hypertension, impaired renal function, neuropathy, retinopathy,
             CVD)

          -  severe diabetes complications or associated medical conditions (such as blindness,
             endstage renal failure, liver cirrhosis, malignancy, chronic congestive heart
             failure)

          -  recent (within preceding 12 months) myocardial infarction, stroke or TIA

          -  unstable angina pectoris

          -  same MOMs Trial exclusion criteria (with the exception of BMI)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kuojen Tsao, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center at Houston - UTHealth.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kuojen Tsao, MD</last_name>
    <phone>713-500-7327</phone>
    <email>KuoJen.Tsao@uth.tmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yisel Morales, B.S.</last_name>
    <phone>713-486-6560</phone>
    <email>yisel.morales@uth.tmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Memorial Hermann Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kuojen Tsao, MD</last_name>
      <phone>713-500-7327</phone>
      <email>KuoJen.Tsao@uth.tmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Yisel Morales, B.S.</last_name>
      <phone>713-486-6560</phone>
      <email>yisel.morales@uth.tmc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Fetal Center at UTHealth</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kuojen Tsao, MD</last_name>
      <phone>713-500-7327</phone>
      <email>KuoJen.Tsao@uth.tmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Yisel Morales, B.S.</last_name>
      <phone>713-486-6560</phone>
      <email>yisel.morales@uth.tmc.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://childrens.memorialhermann.org/the-fetal-center/</url>
    <description>The Fetal Center at Children's Memorial Hermann Hospital</description>
  </link>
  <reference>
    <citation>Adzick NS, Thom EA, Spong CY, Brock JW 3rd, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Dabrowiak ME, Sutton LN, Gupta N, Tulipan NB, D'Alton ME, Farmer DL; MOMS Investigators.. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011 Mar 17;364(11):993-1004. doi: 10.1056/NEJMoa1014379. Epub 2011 Feb 9.</citation>
    <PMID>21306277</PMID>
  </reference>
  <verification_date>January 2016</verification_date>
  <lastchanged_date>January 25, 2016</lastchanged_date>
  <firstreceived_date>January 19, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>KuoJen Tsao</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Myelomeningocele repair</keyword>
  <keyword>Open Neural Tube Defect</keyword>
  <keyword>BMI of 35-40 kg/m2,</keyword>
  <keyword>Open Fetal Surgery</keyword>
  <keyword>Elevated body mass index</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Meningomyelocele</mesh_term>
    <mesh_term>Spina Bifida Cystica</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
